Clinical trials for Hodgkin lymphoma

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Hodgkin lymphoma. For all clinical trials, go to clinical trials search

This list shows clinical trials for Hodgkin lymphoma

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Hodgkin lymphoma
Title Recruitment status Location
Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma Recruiting United Kingdom
Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL) Recruiting United Kingdom
A pilot study to investigate how best to integrate a PET-CT scan into the radiotherapy planning pathway for lymphoma Recruiting United Kingdom
Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Unresponsive to Rituximab or a Rituximab-Containing Regimen Recruiting United Kingdom
Phase I Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma Recruiting United Kingdom
ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas Recruiting United Kingdom
Phase I dose-escalation study of oral administration of S55746 in patients with B-Cell Non-Hodgkin Lymphoma Recruiting United Kingdom
Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant Recruiting United Kingdom
Safety and Tolerability of BAY1862864 Injection in Subjects With Relapsed or Refractory CD22-positive Non-Hodgkin's Lymphoma Recruiting United Kingdom
Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients Recruiting United Kingdom

Page last reviewed: 22/03/2012

Next review due: 22/03/2014